ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Alexion, AstraZeneca Rare Disease at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Alexion, AstraZeneca Rare Disease brings 3 presentations to ACR Convergence 2026 in Orlando. Its program centres on rare disease, including ravulizumab in atypical hemolytic uremic syndrome, adult-onset hypophosphatasia symptoms and a properdin-targeting antibody in a vasculitis model.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
AA Alexion, AstraZeneca Rare Disease | |
AstraZeneca's rare-disease medicines business, formerly Alexion Pharmaceuticals. | Poster Sun Nov 8 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at Alexion, AstraZeneca Rare Disease
Tell us what you sell and we’ll find the people at Alexion, AstraZeneca Rare Disease most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction